title: Gene therapy: primed for take-off.
authors: Philippe
authors: P
authors: Leboulch
mesh_terms: D002553:Cerebroside-Sulfatase / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000378:metabolism*; D006801:Humans; D007966:Leukodystrophy, Metachromatic / Q000628:therapy*; D008297:Male; D014923:Wiskott-Aldrich Syndrome / Q000628:therapy*; D051316:Wiskott-Aldrich Syndrome Protein / Q000235:genetics*
chemical_list: D051316:Wiskott-Aldrich Syndrome Protein; D002553:Cerebroside-Sulfatase
references: Science. 2013 Aug 23;341(6148):1233151
references: 23845947
references: Science. 2009 Nov 6;326(5954):818-23
references: 19892975
references: Science. 2013 Aug 23;341(6148):1233158
references: 23845948
references: Nature. 2010 Sep 16;467(7313):318-22
references: 20844535
references: Nat Rev Genet. 2011 May;12(5):301-15
references: 21445084
references: Stem Cells. 2013 Sep;31(9):1785-94
references: 23712774
references: N Engl J Med. 2010 Nov 11;363(20):1918-27
references: 21067383